Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1914 1
1947 1
1950 1
1951 1
1952 1
1953 1
1954 3
1955 1
1956 1
1959 1
1962 1
1963 1
1969 1
1970 3
1971 1
1972 1
1974 1
1975 1
1977 1
1979 2
1982 1
1983 1
1987 1
1991 1
1992 2
1993 4
1994 3
1995 1
1996 1
1997 1
1998 3
1999 3
2000 1
2002 1
2004 3
2005 2
2008 2
2009 1
2010 2
2011 2
2012 4
2013 2
2014 1
2015 2
2016 3
2017 3
2018 2
2019 4
2020 4
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of the dual SYK/JAK inhibitor cerdulatinib in patients with relapsed or refractory B-cell malignancies: Results of a phase I study.
Hamlin PA, Flinn IW, Wagner-Johnston N, Burger JA, Coffey GP, Conley PB, Michelson G, Leeds JM, Der K, Kim Y, Sabalvaro-Torres A, Birrell M, Pandey A, Curnutte JT, Patel MR. Hamlin PA, et al. Among authors: coffey gp. Am J Hematol. 2019 Apr;94(4):E90-E93. doi: 10.1002/ajh.25387. Epub 2019 Jan 8. Am J Hematol. 2019. PMID: 30592080 Free article. Clinical Trial. No abstract available.
High-pressure apparatus for monitoring solid-liquid phase transitions.
Jones MC, Campbell KB, Coffey MJ, Marina OA, Coffey GW, Heredia-Langner A, Linehan JC, Thomsen EC, Bays JT. Jones MC, et al. Among authors: coffey gw. Rev Sci Instrum. 2020 Sep 1;91(9):094102. doi: 10.1063/5.0015518. Rev Sci Instrum. 2020. PMID: 33003775
Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies.
Coffey GP, Feng J, Betz A, Pandey A, Birrell M, Leeds JM, Der K, Kadri S, Lu P, Segal J, Wang YL, Michelson G, Curnutte JT, Conley PB. Coffey GP, et al. Clin Cancer Res. 2019 Feb 15;25(4):1174-1184. doi: 10.1158/1078-0432.CCR-18-1047. Epub 2018 Oct 17. Clin Cancer Res. 2019. PMID: 30333224 Free article. Clinical Trial.
Antibiotic studies of azaserine.
EHRLICH J, ANDERSON LE, COFFEY GL, HILLEGAS AB, KNUDSEN MP, KOEPSELL HJ, KOHBERGER DL, OYAAS JE. EHRLICH J, et al. Among authors: coffey gl. Nature. 1954 Jan 9;173(4393):72. doi: 10.1038/173072a0. Nature. 1954. PMID: 13132876 No abstract available.
The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia.
Blunt MD, Koehrer S, Dobson RC, Larrayoz M, Wilmore S, Hayman A, Parnell J, Smith LD, Davies A, Johnson PWM, Conley PB, Pandey A, Strefford JC, Stevenson FK, Packham G, Forconi F, Coffey GP, Burger JA, Steele AJ. Blunt MD, et al. Among authors: coffey gp. Clin Cancer Res. 2017 May 1;23(9):2313-2324. doi: 10.1158/1078-0432.CCR-16-1662. Epub 2016 Oct 3. Clin Cancer Res. 2017. PMID: 27697994 Free PMC article.
80 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page